title: Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models.
authors.affiliation: Department of Medicine, Roswell Park Cancer Institute, and SUNY-UB, Buffalo, New York, USA.
authors.forename: Deepika
authors.initials: D
authors.lastname: Lal
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Park
authors.forename: Kellie
authors.initials: K
authors.lastname: Demock
authors.forename: Joseph
authors.initials: J
authors.lastname: Marinaro
authors.forename: Amanda M
authors.initials: AM
authors.lastname: Perez
authors.forename: Mei-Hui
authors.initials: MH
authors.lastname: Lin
authors.forename: Lili
authors.initials: L
authors.lastname: Tian
authors.forename: Terry J
authors.initials: TJ
authors.lastname: Mashtare
authors.forename: Michael
authors.initials: M
authors.lastname: Murphy
authors.forename: Joshua
authors.initials: J
authors.lastname: Prey
authors.forename: Meir
authors.initials: M
authors.lastname: Wetzler
authors.forename: Gerald J
authors.initials: GJ
authors.lastname: Fetterly
authors.forename: Eunice S
authors.initials: ES
authors.lastname: Wang